Multivalent artificial opsonin for the recognition and phagocytosis of Gram-positive bacteria by human phagocytes

Biomaterials

Volumn 32, Issue 16, 2011, Pages 4042-4051

  Katzenmeyer, Kristy N ^a   Bryers, James D ^a  

^a University of Washington   (United States)

Author keywords

Bacteria; Flow cytometry; Immune response; Immunostimulation; Infection; Neutrophil

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBODY FRAGMENT; BACTERIAL STRAINS; CELL LINES; CELL SURFACE RECEPTORS; CELL WALLS; ENTEROCOCCUS FAECALIS; EPIDERMIDIS; GRAM-POSITIVE BACTERIUM; HOSPITAL ACQUIRED INFECTION; HUMAN IGG; HUMAN NEUTROPHIL; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFECTION; L-LYSINE; METHICILLIN; NEUTROPHIL; PATHOGENIC BACTERIUM; PEPTIDE ANALOGS; RESISTANT STRAINS; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN;

AMINO ACIDS; ANTIBIOTICS; ANTIGEN-ANTIBODY REACTIONS; BACTERIOLOGY; CELL CULTURE; CELL MEMBRANES; ETHYLENE; ETHYLENE GLYCOL; FLOW CYTOMETRY; PEPTIDES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES;

BACTERIA;

ACETIC ACID DERIVATIVE; BACTERIAL POLYSACCHARIDE; CELL SURFACE RECEPTOR; DEXTRO ALANINE; FC RECEPTOR; IMMUNOGLOBULIN G; MACROGOL; OPSONIN; POLYLYSINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG CONJUGATION; ENCAPSULATION; ENTEROCOCCUS FAECALIS; FLOW CYTOMETRY; GENE EXPRESSION; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; NONHUMAN; OPSONIZATION; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; CELL SURVIVAL; FLOW CYTOMETRY; GRAM-POSITIVE BACTERIA; HL-60 CELLS; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; OPSONIN PROTEINS; PHAGOCYTES; PHAGOCYTOSIS; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN RESISTANCE;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; POSIBACTERIA; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 79953029878     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.02.007     Document Type: Article

References (52)

1. Gottenbos B., Busscher H.J., Van Der Mei H.C., Nieuwenhuis P. Pathogenesis and prevention of biomaterial centered infections. J Mater Sci-Mater M 2002, 13:717-722.
2. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348(16):1546-1554.
3. Wenzel R.P., Edmond M.B. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 2001, 7(2):174-177.
4. Pollack A. Rising threat of infections unfazed by antibiotics. New York Times 2010 February 27.
5. Klevens R.M., Edwards J.R., Richards C.L., Horan T.C., Gaynes R.P., Pollack D.A., et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007, 122:160-166.
6. Darouiche R. Treatment of infections associated with surgical implants. New Engl J Med 2004, 350:1422-1429.
7. Gotz F. Staphylococcus and biofilms. Mol Microbiol 2002, 43(6):1367-1378.
8. Otto M. Staphylococcus epidermidis - the 'accidental' pathogen. Nat Rev Microbiol 2009, 7:555-567.
9. Hellmark B., Unemo M., Nilsdotter-Augustinsson A., Söderquist B. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene. Clin Microbiol Infec 2009, 15(3):238-244.
10. Neu H. The crisis in antibiotic resistance. Science 1992, 257:1064-1073.
11. Foster T. Immune evasion by staphylococci. Nat Rev Microbiol 2005, 3:948-958.
12. Kocianova S., Vuong C., Yao Y., Voyich J.M., Fischer E.R., DeLeo F.R., et al. Key role of poly-γ-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. J Clin Invest 2005, 115(3):688-694.
13. Peterson P.K., Wilkinson B.J., Kim Y., Schmeling D., Quie P.G. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun 1978, 19(3):943-949.
14. Lindorfer M.A., Nardin A., Foley P.L., Solga M.D., Bankovich A.J., Martin E.N., et al. Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies. J Immunol 2001, 167:2240-2249.
15. Kobayashi T., Takauchi A., van Spriel A.B., Vilé H.A., Hayakawa M., Shibata Y., et al. Targeting of Porphyromonas gingivalis with a bispecific antibody directed to FcαRI (CD89) improves in vitro clearance by gingival crevicular neutrophils. Vaccine 2004, 23:585-594.
16. Gyimesi E., Bankovich A.J., Schuman T.A., Goldberg J.B., Lindorfer M.A., Taylor R.P. Staphylococcus aureus bound to complement receptor 1 on human erythrocytes by bispecific monoclonal antibodies is phagocytosed by acceptor macrophages. Immunol Lett 2004, 95:185-192.
17. Tomita G.M., Wang Y., Paape M.J., Poultrel B., Rainard P. Influence of bispecific antibodies on the in vitro bactericidal activity of bovine neutrophils against Staphylococcus aureus. J Dairy Sci 2000, 83(10):2269-2271.
18. Kuhn S.E., Nardin A., Klebba P.E., Taylor R.P. Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model. J Immunol 1998, 160:5088-5097.
19. Bruno J.G., Carrillo M.P., Crowell R. Preliminary development of DNA aptamer-Fc conjugate opsonins. J Biomed Mater Res 2009, 90A:1152-1161.
20. Mammen M., Choi S.-K., Whitesides G.M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 1998, 37:2754-2794.
21. Krishnamurthy V.M., Quinton L.J., Estroff L.A., Metallo S.J., Isaacs J.M., Mizgerd J.P., et al. Promotion of opsonization by antibodies and phagocytosis of Gram-positive bacteria by a bifunctional polyacrylamide. Biomaterials 2006, 27:3663-3674.
22. Immunobiology. The immune system in health and disease 2005, Garland Science Publishing, New York. 6th ed. C.A. Janeway, P. Travers, M. Walport, M.J. Shlomchik (Eds.).
23. Ivan E., Colovai A.I. Human Fc receptors: criticial targets in the treatment of autoimmune diseases and transplant rejections. Hum Immunol 2006, 67:479-491.
24. Huynh K.K., Grinstein S. Receptor-initiated signal transduction during phagocytosis. Phagocytosis and bacterial pathogenicity 2006, Cambridge University Press, New York, NY. J.D. Ernst, O. Stendahl (Eds.).
25. Fang F.C. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2004, 2:820-832.
26. Scherrer R., Gerhardt P. Molecular sieving by the Bacillus megaterium cell wall and protoplast. J Bacteriol 1971, 107(3):718-735.
27. Idusogie E.E., Presta L.G., Gazzano-Santoro H., Totpal K., Wong P.Y., Ultsch M., et al. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J Immunol 2000, 164:4178-4184.
28. Mack D., Siemssen N., Laufs R. Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion. Infect Immun 1992, 60(5):2048-2057.
29. Shlaes D.M., Bouvet A., Devine C., Shlaes J.H., Al-Obeid S., Williamson R. Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256. Antimicrob Agent Chemother 1989, 33(2):198-203.
30. Ge M., Chen Z., Onishi H.R., Kohler J., Silver L.L., Kerns R., et al. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Science 1999, 284:507-511.
31. Metallo S.J., Kane R.S., Holmlin R.E., Whitesides G.M. Using bifunctional polymers presenting vancomycin and fluorescein groups to direct anti-fluorescein antibodies to self-assembled monolayers presenting D-alanine-D-alanine groups. J Am Chem Soc 2003, 125(15):4534-4540.
32. Fraimow H.S., Courvalin P. Resistance to glycopeptides in Gram-positive pathogens. Gram-positive pathogens 2006, 782-800. ASM Press, Washington, DC. V.A. Fischetti, R.P. Novick, J.J. Ferretti, D.A. Portnoy, J.I. Rood (Eds.).
33. Hiramatsu K. Vancomycin resistance in staphylococci. Drug Resist Updates 1998, 1:135-150.
34. Cui L., Iwamoto A., Lian J.-Q., Neoh H.-M., Maruyama T., Horikawa Y., et al. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agent Chemother 2006, 50(2):428-438.
35. Cui L., Murakami H., Kuwahara-Arai K., Hanaki H., Hiramatsu K. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agent Chemother 2000, 44(9):2276-2285.
36. Wagner V.E., Koberstein J.T., Bryers J.D. Protein and bacterial fouling characteristics of peptide and antibody decorated surfaces of PEG-poly(acrylic acid) co-polymers. Biomaterials 2004, 25(12):2247-2263.
37. Cheng G., Zhang Z., Chen S., Bryers J.D., Jiang S. Inhibition of bacterial adhesion and biofilm formation on zwitterionic surfaces. Biomaterials 2007, 28(29):4192-4199.
38. Jarvis R.A., Bryers J.D. Effects of controlled fibronectin surface orientation on subsequent Staphylococcus epidermidis adhesion. J Biomed Mater Res A 2005, 75(1):41-55.
39. Sun D., Accavitti M.A., Bryers J.D. Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein. Clin Diagn Lab Immunol 2005, 12(1):93-100.
40. Tojo M., Yamashita N., Goldmann D.A., Pier G.B. Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J Infect Dis 1988, 157:713-722.
41. Wang I.W., Anderson J.M., Marchant R.E. Staphylococcus epidermidis adhesion to hydrophobic biomedical polymer is mediated by platelets. J Infect Dis 1993, 167(2):329-336.
42. Cheung G.Y., Rigby K., Wang R., Queck S.Y., Braughton K.R., Whitney A.R., et al. Staphylococcus epidermidis strategies to avoid killing by human neutrophils. PLoS Pathog 2010, 6(10). pii:e1001133.
43. Christensen G.D., Bisno A.L., Parisi J.T., McLaughlin B., Luther R.W. Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Ann Intern Med 1982, 96:1-10.
44. Christensen G.D., Parisi J.T., Bisno A.L., Simpson W.A., Beachey E.H. Characterization of clinically significant strains of coagulase-negative staphylococci. J Clin Microbiol 1983, 18:258-269.
45. Baptista M., Depardieu F., Courvalin P., Arthur M. Specificity of induction of glycopeptide resistance genes in Enterococcus faecalis. Antimicrob Agents Chemother 1996, 40(10):2291-2295.
46. Arthur M., Depardieu F., Gerbaud G., Galimand M., Leclercq R., Courvalin P. The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction. J Bacteriol 1997, 179(1):97-106.
47. Courvalin P. Vancomycin resistance in Gram-positive cocci. Clin Infect Dis 2006, 42:S25-S34.
48. Dong S., Oberthür M., Losey H.C., Anderson J.W., Eggert U.S., Peczuh M.W., et al. The structural basis for induction of VanB resistance. J Am Chem Soc 2002, 124:9064-9065.
49. Swenson J.M., Clark N.C., Sahm D.F., Ferraro M.J., Doern G., Hindler J., et al. Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J Clin Microbiol 1995, 33(11):3019-3021.
50. Walsh C.T., Fisher S.L., Park I.-S., Prahalad M., Wu Z. Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem Biol 1996, 3:21-28.
51. Arthur M. Vancomycin sensing. Nat Chem Biol 2010, 6:313-315.
52. Koteva K., Hong H.-J., Wang X.D., Nazi I., Hughes D., Naldrett M.J., et al. A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor. Nat Chem Biol 2010, 6:327-329.